IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation
Authors
Keywords
-
Journal
Nature Communications
Volume 7, Issue -, Pages 13567
Publisher
Springer Nature
Online
2016-11-23
DOI
10.1038/ncomms13567
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Retrospective analysis of metastatic behaviour of breast cancer subtypes
- (2015) C. Dilara Savci-Heijink et al. BREAST CANCER RESEARCH AND TREATMENT
- PIK3CA Mutations Are Associated With Decreased Benefit to Neoadjuvant Human Epidermal Growth Factor Receptor 2–Targeted Therapies in Breast Cancer
- (2015) Ian J. Majewski et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
- (2015) Sara A Hurvitz et al. LANCET ONCOLOGY
- ActivatingPIK3CAMutations Induce an Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-regulated Kinase (ERK) Paracrine Signaling Axis in Basal-like Breast Cancer
- (2015) Christian D. Young et al. MOLECULAR & CELLULAR PROTEOMICS
- The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins
- (2015) Fumihiko Hakuno et al. Frontiers in Endocrinology
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Fabrice André et al. LANCET ONCOLOGY
- Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents
- (2013) Ingar Seemann et al. BREAST CANCER RESEARCH AND TREATMENT
- The Omics of Triple-Negative Breast Cancers
- (2013) H. Xu et al. CLINICAL CHEMISTRY
- Analysis of Tumor Heterogeneity and Cancer Gene Networks Using Deep Sequencing of MMTV-Induced Mouse Mammary Tumors
- (2013) Christiaan Klijn et al. PLoS One
- Effect of IRS4 Levels on PI 3-Kinase Signalling
- (2013) Gerta Hoxhaj et al. PLoS One
- Simultaneous Translocation of BothTCRLoci (14q11) with Rare Partner Loci (Xq22 and 12p13) in a Case of T-lymphoblastic Leukemia
- (2012) Dong-Hee Kang et al. Annals of Laboratory Medicine
- Molecular Basis of Signaling Specificity of Insulin and IGF Receptors: Neglected Corners and Recent Advances
- (2012) Kenneth Siddle Frontiers in Endocrinology
- Nuclear IRS-1 and cancer
- (2011) Krzysztof Reiss et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The t(X;6) in subungual exostosis results in transcriptional deregulation of the gene for insulin receptor substrate 4
- (2010) Fredrik Mertens et al. INTERNATIONAL JOURNAL OF CANCER
- Altered Glucose Homeostasis in Mice with Liver-specific Deletion of Src Homology Phosphatase 2
- (2010) Kosuke Matsuo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies
- (2010) LANCET ONCOLOGY
- Expression and function of the insulin receptor substrate proteins in cancer
- (2009) Katerina Mardilovich et al. Cell Communication and Signaling
- PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
- (2009) Elena López-Knowles et al. INTERNATIONAL JOURNAL OF CANCER
- The t(X;7)(q22;q34) in paediatric T-cell acute lymphoblastic leukaemia results in overexpression of the insulin receptor substrate 4 gene through illegitimate recombination with the T-cell receptor beta locus
- (2008) Kristina Karrman et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Central Role for HER3 in HER2-Amplified Breast Cancer: Implications for Targeted Therapy
- (2008) S. T. Lee-Hoeflich et al. CANCER RESEARCH
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
- (2008) P. J.A. Eichhorn et al. CANCER RESEARCH
- Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks
- (2008) Anthony G. Uren et al. CELL
- Insulin Receptor Substrates (IRSs) and Breast Tumorigenesis
- (2008) Bonita Tak-Yee Chan et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- The Identification of 2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a Potent, Selective, Orally Bioavailable Inhibitor of Class I PI3 Kinase for the Treatment of Cancer†
- (2008) Adrian J. Folkes et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Phosphotyrosine Interactome of the Insulin Receptor Family and Its Substrates IRS-1 and IRS-2
- (2008) Stefan Hanke et al. MOLECULAR & CELLULAR PROTEOMICS
- Insulin Receptor Substrate 4 Couples the Leptin Receptor to Multiple Signaling Pathways
- (2007) Joris Wauman et al. MOLECULAR ENDOCRINOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started